PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization
出版年份 2020 全文链接
标题
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume -, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-10-08
DOI
10.1161/atvbaha.120.315168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic strategies for thrombosis: new targets and approaches
- (2020) Nigel Mackman et al. NATURE REVIEWS DRUG DISCOVERY
- Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
- (2020) Benjamin M. Scirica et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy
- (2019) Kevin Bliden et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction
- (2019) Andrew R. Chapman et al. CIRCULATION
- European Society of Cardiology: Cardiovascular Disease Statistics 2019
- (2019) Adam Timmis et al. EUROPEAN HEART JOURNAL
- Noncanonical Matrix Metalloprotease 1–Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisHighlights
- (2018) Rajashree Rana et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial
- (2018) Anoop S V Shah et al. LANCET
- Acute myocardial infarction
- (2017) Grant W Reed et al. LANCET
- Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis
- (2016) T. Petzold et al. Science Translational Medicine
- Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- G-Protein–Coupled Receptors Signaling Pathways in New Antiplatelet Drug DevelopmentSignificance
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics
- (2015) Ping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease
- (2013) Christopher P. Cannon et al. CIRCULATION
- Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts
- (2013) Dmitry L. Sonin et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin
- (2012) Ping Zhang et al. CIRCULATION
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. CIRCULATION
- Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development
- (2012) Katie O'Callaghan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention
- (2011) Carey Kimmelstiel et al. Circulation-Cardiovascular Interventions
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- SCH 602539, a Protease-Activated Receptor-1 Antagonist, Inhibits Thrombosis Alone and in Combination With Cangrelor in a Folts Model of Arterial Thrombosis in Cynomolgus Monkeys
- (2010) Madhu Chintala et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
- (2009) Vishal Trivedi et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now